Trial Profile
Gene-by-Stress Interactions in Intervention Studies Significance
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Lorcaserin (Primary) ; Ziprasidone (Primary)
- Indications Bipolar disorders; Obesity
- Focus Pharmacodynamics
- 13 Feb 2020 Status changed from recruiting to discontinued.
- 15 Feb 2018 Status changed from not yet recruiting to recruiting.
- 10 Jan 2017 New trial record